Frontlight ResearchEarly access
Childhood cancers trials in China
609 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peoplePolymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia
- Where
- Beijing
- Age
- 14 years to 85 years
- People
- 10
- Run by
- Daihong Liu
See details and how to joinNCT07321301 - Early phase 1Taking peopleJY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- Kunming
- Age
- Up to 75 years
- People
- 20
- Run by
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
See details and how to joinNCT06514768 - No phaseNot yet taking people in ChinaPreliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia
- Where
- Zhengzhou
- Age
- 10 years to 17 years
- People
- 60
- Run by
- The Hong Kong Polytechnic University
See details and how to joinNCT07319481 - No phaseTaking peopleUsing Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML
- Where
- Beijing
- Age
- Up to 18 years
- People
- 283
- Run by
- Peking University People's Hospital
See details and how to joinNCT06452732 - Phase 2Taking peopleCAV Regimen for R/R AML
- Where
- Suzhou
- Age
- 16 years to 70 years
- People
- 68
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT05657639 - No phaseTaking peopleCAV Regimen for R/R Ph- B-ALL
- Where
- Suzhou
- Age
- 15 years to 70 years
- People
- 36
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT05657652 - Phase 1Taking peopleA Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade Glioma
- Where
- Hangzhou
- Age
- 16 years and over
- People
- 10
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07306299 - Phase 3Taking peopleEffect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
- Where
- Hefei
- People
- 134
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT07047456 - Phase 2Taking peopleA Prospective Multicenter Clinical Study of SCCG Protocol and ctDNA 5hmc in Predicting the Chemotherapy Sensitivity and Monitoring the Recurrence and Metastasis of Hepatoblastoma in Children and Adolescents
- Where
- Guangzhou
- Age
- Up to 18 years
- People
- 100
- Run by
- Sun Yat-sen University
See details and how to joinNCT07300449 - Phase 1Taking peoplePhase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia
- Where
- Beijing
- Age
- 15 years and over
- People
- 5
- Run by
- Beijing 302 Hospital
See details and how to joinNCT07297173 - Phase 2Taking peopleTo Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years
- Where
- Nanning
- Age
- 9 years to 45 years
- People
- 330
- Run by
- Shanghai Bovax Biotechnology Co., Ltd.
See details and how to joinNCT06756269 - Phase 2Taking peopleVenetoclax Combined With Azactidine in the Treatment of ALAL
- Where
- Suzhou
- Age
- 15 years and over
- People
- 23
- Run by
- Sheng-Li Xue, MD
See details and how to joinNCT05901974 - Phase 2Taking peopleEfficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Line Treatment
- Where
- Zhejiang
- People
- 20
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT07285941 - No phaseNot yet taking people in ChinaImproving Chemotherapy Induced Peripheral Neuropathy in Children With Leukemia: A Study of Transcutaneous Acupoints Electrical Stimulation and Auricular Acupressure Interventions
- Where
- Shanghai
- Age
- 8 years to 17 years
- People
- 132
- Run by
- The Hong Kong Polytechnic University
See details and how to joinNCT07279818 - Phase 1Taking peopleTo Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT
- Where
- Beijing
- Age
- 3 years to 80 years
- People
- 18
- Run by
- Peking University People's Hospital
See details and how to joinNCT07280494 - No phaseTaking peopleRenal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
- Where
- Nanjing
- People
- 450
- Run by
- Jinling Hospital, China
See details and how to joinNCT05917106 - No phaseNot yet taking people in ChinaPSMA-PET/MRI-Ultrasound Multimodal Fusion Navigation for Da Vinci Robot-Assisted Radical Prostatectomy: A Randomized Controlled Trial
- Where
- Shanghai
- Age
- Up to 90 years
- People
- 98
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07272317 - No phaseTaking peoplePediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China
- Where
- Hangzhou
- Age
- 29 days to 18 years
- People
- 108
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07113808 - Phase 4Taking peopleZanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
- Where
- Suzhou
- Age
- 14 years to 80 years
- People
- 40
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT07270835 - No phaseTaking peopleHealth Behavior Change in High-Risk Colorectal Cancer Individuals
- Where
- Shenyang
- Age
- 18 months to 80 months
- People
- 80
- Run by
- China Medical University, China
See details and how to joinNCT07262840 - Phase 2Taking peopleThe Optimal Radioimmunotherapy Combinations for Advanced TNBC
- Where
- Guangzhou
- People
- 60
- Run by
- Sun Yat-sen University
See details and how to joinNCT06735131 - No phaseTaking peopleHetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma
- Where
- Beijing
- Age
- Up to 18 years
- People
- 30
- Run by
- Beijing Children's Hospital
See details and how to joinNCT06818916 - Phase 2Taking peopleThe Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer
- Where
- Hangzhou
- Age
- 10 years to 85 years
- People
- 70
- Run by
- Zhejiang University
See details and how to joinNCT07257653 - No phaseTaking peopleDevelopment and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis
- Where
- Guangzhou
- People
- 10,000
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06517979 - Phase 1/2Taking peopleAutologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies
- Where
- Beijing, Chengdu, Shanghai
- Age
- 1 year to 70 years
- People
- 80
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT06316427